HomePDSB • NASDAQ
PDS Biotechnology Corp
add
$1.65
7.84%
Pre-market:(3.03%)-0.050
$1.60
Closed: Jun 5, 4:18:44 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.11M | -9.82% |
Net income | -8.49M | 19.94% |
Net profit margin | — | — |
Earnings per share | -0.21 | 30.00% |
EBITDA | -9.09M | 9.84% |
Effective tax rate | 12.11% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.69M | -37.44% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 19.00M | — |
Shares outstanding | 45.40M | — |
Price to book | 3.06 | — |
Return on assets | — | — |
Return on capital | -55.75% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.49M | 19.94% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$1.53
Day range
$1.53 - $1.68
Year range
$0.85 - $4.42
Market cap
75.42M USD
Avg Volume
585.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Website
Employees
24
